| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-07 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-07 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.35 | 1e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |